Phase III, randomized, open-label, comparative safety and efficacy trial of IV iron isomaltoside (Monofer®) and iron sucrose (Venofer) in subjects with iron deficiency anemia who are intolerant or unresponsive to oral iron therapy or in whom the hemoglobin measurement in Investigators' opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of receiving a blood transfusion. - Regional Cancer Care Associates LLC

Clinical Trials

Phase III, randomized, open-label, comparative safety and efficacy trial of IV iron isomaltoside (Monofer®) and iron sucrose (Venofer) in subjects with iron deficiency anemia who are intolerant or unresponsive to oral iron therapy or in whom the hemoglobin measurement in Investigators’ opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of receiving a blood transfusion.

Type of Cancer
Unknown
Locations
Bethesda
Sponsor
Protocol Number
P-MONOFER-IDA-03
Cancer Diagnosis
To Learn More Call
201-510-0910